FDA Alert: Relenza (zanamivir) Inhalation Powder

Links shared publicly online about this topic.

  • 1,689
    total visits

FDA Alert: Relenza (zanamivir) Inhalation Powder

drugs.com

FDA Alert: Relenza (zanamivir) Inhalation Powder

View full resource at drugs.com

Tags: Flu Medication, FDA, Relenza, GlaxoSmithKline

  • Share

Most Recently Shared on October 9, 2009 at 10:18 pm By:

drugscom Drugs.com

FDA Alert - GSK and FDA Warn Against Nebulization of Relenza (zanamivir) Inhalation Powder - http://bit.ly/2f9w7Q

3 years ago...

FDA warns that Relenza is not to be administered by nebulizer or mechanical ventilator - MPR

empr.com — “The FDA and GlaxoSmithKline have notified healthcare professionals of a report of the death of a patient with influenza who received Relenza (zanamivir) inhalation powder which was solubilized and administered by mechanical ventilation.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on October 12, 2009 at 4:18 pm By:

eMPR MPR Medical Publisher

MPR News: FDA warns that Relenza is not to be administered by nebulizer or mechanical ventilator: The .. http://tinyurl.com/yznjawy

3 years ago...

FDA Safety Alert: Nebulizing Relenza Inhalation Powder

examiner.com — “In a Food and Drug Administration MedWatch released October 9, 2009, GlaxoSmithKline (GSK), the manufacturer of Relenza (zanamivir), received a report of a death of a patient who received the drug solubilized and administered by mechanical …View full resource at examiner.com

  • View Related
  • Share

Most Recently Shared on October 10, 2009 at 3:06 am By:

MiriamETucker Miriam E. Tucker Patient Expert

RT @bactiman63: FDA Safety Alert: Nebulizing Relenza Inhalation Powder - http://shar.es/1d4Kd

3 years ago...

Advertisement